These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27206931)

  • 21. Chylomicronemia caused by lipoprotein lipase gene mutation related to a hyper-response of insulin secretion to glucose.
    Tanaka S; Tanabe Y; Tamura H; Ishii S; Shuto Y; Kamegai J; Sugihara H; Kobayashi M; Wakabayashi I; Murano T; Shirai K; Oikawa S
    Intern Med; 2002 Apr; 41(4):300-3. PubMed ID: 11993791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting APOC3 in the familial chylomicronemia syndrome.
    Gaudet D; Brisson D; Tremblay K; Alexander VJ; Singleton W; Hughes SG; Geary RS; Baker BF; Graham MJ; Crooke RM; Witztum JL
    N Engl J Med; 2014 Dec; 371(23):2200-6. PubMed ID: 25470695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipoprotein lipase deficiency in an infant.
    Nampoothiri S; Radhakrishnan N; Schwentek A; Hoffmann MM
    Indian Pediatr; 2011 Oct; 48(10):805-6. PubMed ID: 22080683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compound heterozygosity for a known (D250N) and a novel (E410K) missense mutation in the C-terminal domain of lipoprotein lipase causes familial chylomicronemia.
    Wiebusch H; Funke H; Bruin T; Bucher H; von Eckardstein A; Kastelein JJ; Assmann G
    Hum Mutat; 1996; 8(4):381-3. PubMed ID: 8956048
    [No Abstract]   [Full Text] [Related]  

  • 25. A missense mutation (Trp86----Arg) in exon 3 of the lipoprotein lipase gene: a cause of familial chylomicronemia.
    Ishimura-Oka K; Faustinella F; Kihara S; Smith LC; Oka K; Chan L
    Am J Hum Genet; 1992 Jun; 50(6):1275-80. PubMed ID: 1598907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical characteristics of hypertriglyceridemia-induced pancreatitis].
    Kubo M
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():698-701. PubMed ID: 11351673
    [No Abstract]   [Full Text] [Related]  

  • 27. The Chylomicronemia Syndrome Is Most Often Multifactorial: A Narrative Review of Causes and Treatment.
    Chait A; Eckel RH
    Ann Intern Med; 2019 May; 170(9):626-634. PubMed ID: 31035285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical, biochemical and molecular analysis of two infants with familial chylomicronemia syndrome.
    Zhang Y; Zhou J; Zheng W; Lan Z; Huang Z; Yang Q; Liu C; Gao R; Zhang Y
    Lipids Health Dis; 2016 May; 15():88. PubMed ID: 27153815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chylomicron].
    Shimazu N
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():34-7. PubMed ID: 15658256
    [No Abstract]   [Full Text] [Related]  

  • 30. Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II.
    Fojo SS; Brewer HB
    J Intern Med; 1992 Jun; 231(6):669-77. PubMed ID: 1619390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe Hypertriglyceridemia due to a novel p.Q240H mutation in the Lipoprotein Lipase gene.
    Soto AG; McIntyre A; Agrawal S; Bialo SR; Hegele RA; Boney CM
    Lipids Health Dis; 2015 Sep; 14():102. PubMed ID: 26337181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene.
    Benlian P; De Gennes JL; Foubert L; Zhang H; Gagné SE; Hayden M
    N Engl J Med; 1996 Sep; 335(12):848-54. PubMed ID: 8778602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analyses of familial chylomicronemia syndrome in Pereira, Colombia 2010-2020: a cross-sectional study.
    Rodriguez FH; Estrada JM; Quintero HMA; Nogueira JP; Porras-Hurtado GL
    Lipids Health Dis; 2023 Mar; 22(1):43. PubMed ID: 36978188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chylomicronemia syndrome. Interaction of genetic and acquired hypertriglyceridemia.
    Brunzell JD; Bierman EL
    Med Clin North Am; 1982 Mar; 66(2):455-68. PubMed ID: 7040847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial chylomicronemia syndrome.
    Mohandas MK; Jemila J; Ajith Krishnan AS; George TT
    Indian J Pediatr; 2005 Feb; 72(2):181. PubMed ID: 15758547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Familial hyperchylomicronemia syndrome].
    Tada N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():13-21. PubMed ID: 11347044
    [No Abstract]   [Full Text] [Related]  

  • 37. Familial chylomicronemia syndrome. A sixty year follow-up in two siblings and their kindreds. Nosological and clinical considerations.
    Vigna GB; Citroni N; Tarugi P; Fellin R
    J Clin Lipidol; 2022; 16(5):591-595. PubMed ID: 35945124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity.
    Brunzell JD; Miller NE; Alaupovic P; St Hilaire RJ; Wang CS; Sarson DL; Bloom SR; Lewis B
    J Lipid Res; 1983 Jan; 24(1):12-9. PubMed ID: 6833877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat.
    Blackett P; Tryggestad J; Krishnan S; Li S; Xu W; Alaupovic P; Quiroga C; Copeland K
    J Clin Lipidol; 2013; 7(2):132-9. PubMed ID: 23415432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of type I hyperlipoproteinemia.
    Gnasso A; Koch H; Haberbosch W; Fellin R; Postiglione A; Augustin J
    Monogr Atheroscler; 1986; 14():135-9. PubMed ID: 3736552
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.